Sun W, Xiong J, Shulman M J
Department of Immunology, University of Toronto, Ontario, Canada.
J Immunol. 1994 Jan 15;152(2):695-704.
Homologous recombination between transferred and chromosomal Ig genes in mouse hybridoma cells offers a general method of altering the chromosomal Ig genes in predetermined ways. Recombination is infrequent in hybridoma cells, and we have been interested in improving the methods for identifying and recovering the rare recombinants. We have used vectors that are designed to replace the mouse chromosomal C kappa segment with the human equivalent, so that recombinants produce mouse V/human C chimeric kappa-chains. We describe an enhancerless, replacement type vector that can be used with the herpes thymidine kinase counterselection to provide such enrichment that homologous recombinants constitute 15% of the selected G418-resistant, FIAU-resistant cells. We have also measured the level of chimeric kappa gene expression and found surprisingly that (1) it is very variable among transformants with the same recombinant gene structure, (2) there is no systematic difference in the level of production by recombinants that retain or have lost the J-C kappa intron enhancer, and (3) the amount of chimeric kappa mRNA in even the highest producing transformants is much less than the amount of the corresponding mouse kappa mRNA.
小鼠杂交瘤细胞中转染的免疫球蛋白(Ig)基因与染色体Ig基因之间的同源重组提供了一种以预定方式改变染色体Ig基因的通用方法。同源重组在杂交瘤细胞中很少发生,我们一直致力于改进识别和回收罕见重组体的方法。我们使用了一些载体,这些载体被设计用来用人的等效基因取代小鼠染色体的Cκ片段,这样重组体就能产生小鼠V/人C嵌合κ链。我们描述了一种无增强子的置换型载体,它可以与疱疹胸苷激酶反选择一起使用,以实现如此高的富集,以至于同源重组体占所选的G418抗性、FIAU抗性细胞的15%。我们还测量了嵌合κ基因的表达水平,令人惊讶地发现:(1)在具有相同重组基因结构的转化体中,其表达水平变化很大;(2)保留或缺失J-Cκ内含子增强子的重组体在产生水平上没有系统性差异;(3)即使是产生量最高的转化体中,嵌合κ mRNA的量也远低于相应小鼠κ mRNA的量。